Post-Marketing Surveillance of Tetravalent Diphtheria-Tetanus-Acellular Pertussis and Inactivated Poliovirus (DTaP-IPV) Vaccine in South Korea, 2009 to 2015

INTRODUCTION: TETRAXIM™ (Sanofi), a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus (DTaP-IPV) vaccine, has been licensed in South Korea since 2009. In accordance with the Ministry of Food and Drug Safety regulations, this post-marketing surveillance (PMS) study evaluat...

Descripción completa

Detalles Bibliográficos
Autores principales: Choe, Young June, Vidor, Emmanuel, Manson, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334467/
https://www.ncbi.nlm.nih.gov/pubmed/35575974
http://dx.doi.org/10.1007/s40121-022-00650-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334467/
https://www.ncbi.nlm.nih.gov/pubmed/35575974
http://dx.doi.org/10.1007/s40121-022-00650-8

Ejemplares similares